These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 9524709)

  • 1. Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma.
    Mooney MM; Kulas M; McKinley B; Michalek AM; Kraybill WG
    Ann Surg Oncol; 1998; 5(1):54-63. PubMed ID: 9524709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
    Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
    J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
    Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
    Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
    Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
    Leon-Ferre RA; Kottschade LA; Block MS; McWilliams RR; Dronca RS; Creagan ET; Allred JB; Lowe VJ; Markovic SN
    Melanoma Res; 2017 Aug; 27(4):335-341. PubMed ID: 28296712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rational approach to the follow-up of melanoma patients.
    Garbe C
    Recent Results Cancer Res; 2002; 160():205-15. PubMed ID: 12079215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
    Moore Dalal K; Zhou Q; Panageas KS; Brady MS; Jaques DP; Coit DG
    Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure.
    Peethambaram P; Weiss M; Loprinzi CL; Novotny P; O'Fallon JR; Erlichman C; O'Connell MJ; Laurie JA
    Oncology; 1997; 54(4):287-92. PubMed ID: 9216852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Symptoms Are the Most Frequent Indicators of Recurrence in Patients with American Joint Committee on Cancer Stage II Melanoma.
    Berger AC; Ollila DW; Christopher A; Kairys JC; Mastrangelo MJ; Feeney K; Dabbish N; Leiby B; Frank JA; Stitzenberg KB; Meyers MO
    J Am Coll Surg; 2017 Apr; 224(4):652-659. PubMed ID: 28189663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.
    Park TS; Phan GQ; Yang JC; Kammula U; Hughes MS; Trebska-McGowan K; Morton KE; White DE; Rosenberg SA; Sherry RM
    Ann Surg Oncol; 2017 Apr; 24(4):947-951. PubMed ID: 28144760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.
    Garbe C; Paul A; Kohler-Späth H; Ellwanger U; Stroebel W; Schwarz M; Schlagenhauff B; Meier F; Schittek B; Blaheta HJ; Blum A; Rassner G
    J Clin Oncol; 2003 Feb; 21(3):520-9. PubMed ID: 12560444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of the detection of metastases and follow-up examinations in cutaneous melanoma.
    Leiter U; Marghoob AA; Lasithiotakis K; Eigentler TK; Meier F; Meisner C; Garbe C
    Melanoma Res; 2009 Feb; 19(1):50-7. PubMed ID: 19430406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-Based Detection Methods and Recurrence Patterns for Cutaneous Melanoma.
    Sullivan FG; Adler KB; Boudreaux MD; Hensley LM; Roberts ME; Liles JS; Howard JH
    Am Surg; 2024 Jul; 90(7):1963-1965. PubMed ID: 38549200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survival.
    Hofmann U; Szedlak M; Rittgen W; Jung EG; Schadendorf D
    Br J Cancer; 2002 Jul; 87(2):151-7. PubMed ID: 12107834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
    Tas F; Erturk K
    Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
    Reintgen DS; Cox C; Slingluff CL; Seigler HF
    Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
    Francken AB; Thompson JF; Bastiaannet E; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):557-62. PubMed ID: 18402322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: a cost-effectiveness analysis.
    Mooney MM; Mettlin C; Michalek AM; Petrelli NJ; Kraybill WG
    Cancer; 1997 Sep; 80(6):1052-64. PubMed ID: 9305705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma.
    Wang TS; Johnson TM; Cascade PN; Redman BG; Sondak VK; Schwartz JL
    J Am Acad Dermatol; 2004 Sep; 51(3):399-405. PubMed ID: 15337983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.